SEC ownership of AtriCure, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001323885.

Comparable stake leader

BlackRock, Inc.

Disclosed value leader

BlackRock, Inc.

Comparable rows

50/50

Latest evidence

05 Aug 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
05 Aug 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001323885
Issuer location
Mason, OH

Ownership snapshot

Top shareholders of AtriCure, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
05 Aug 2026
13D/G 13F 3/4/5 Lead comparable stake: 7.8% 13D/G row: BlackRock, Inc. Showing 1-8 of 50 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 7.8%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 7.8%
WELLINGTON MANAGEMENT GROUP LLP 6.8%
Hood River Capital Management LLC 6.2%
VANGUARD PORTFOLIO MANAGEMENT LLC 5.5%
VANGUARD CAPITAL MANAGEMENT LLC 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
7.8%
$136,165,391
3,862,837 shares
$0 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP
13D/G
6.8%
$96,504,294
3,382,555 shares
-$16,738,950 31 Mar 2026
Hood River Capital Management LLC
13D/G
6.2%
$122,501,931
3,096,611 shares
+$6,839,133 31 Dec 2025
VANGUARD PORTFOLIO MANAGEMENT LLC
13D/G
Vanguard Portfolio Management
5.5%
$78,305,863
2,744,685 shares
$0 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G
Vanguard Capital Management
5.1%
$72,265,491
2,532,965 shares
$0 31 Mar 2026
MACQUARIE GROUP LTD
13D/G
Macquarie Group Limited
4.6%
$80,700,257
2,289,369 shares
-$7,537,719 30 Sep 2025
Champlain Investment Partners, LLC
13D/G 13F
Company
4.4%
$71,407,964
2,137,963 shares
-$21,803,353 31 Mar 2025
Michael H. Carrel
3/4/5
President, CEO, & Director, Director
1.6%
$22,243,769
794,944 shares
30 Jul 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$3,217,922.

Buys
$0
Insiders: 0
Sells
$3,217,922
Insiders: 5
Net
-$3,217,922
Shares: -88,412
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 88,412
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 47,246 $0 $1,777,845 -$1,777,845
3-6 0 10,000 $0 $289,800 -$289,800
6-9 0 18,166 $0 $676,378 -$676,378
9-12 0 13,000 $0 $473,900 -$473,900

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 21 reporting-owner rows connected to AtriCure, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
21
Largest Forms 3/4/5 holder
Michael H. Carrel
Net 12M change
-$3,217,923
Latest report
05 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Michael H. Carrel President, CEO, & Director, Director $22,243,769 Mixed 30 Jul 2026
Douglas J. Seith Chief Operating Officer $6,558,105 Mixed 30 Jun 2026
Angela L. Wirick Chief Financial Officer $6,404,955 Mixed 01 Mar 2026
Salvatore Privitera Chief Technical Officer $4,527,254 Mixed 30 Jun 2026
Mark R. Lanning Director $4,329,093 Mixed 05 May 2021
Justin J. Noznesky Chief Mktg & Strategy Officer $3,888,497 -$541,402 -12% Filing P/S 29 Jul 2026
Robert S. White Director $3,660,912 Mixed 18 May 2026
Vinayak S. Doraiswamy Chief Scientific Officer $3,363,547 -$523,080 -13% Filing P/S 28 Jul 2026
Mark A. Collar Director $3,221,228 Mixed 13 Mar 2023
Karl S. Dahlquist Chief Legal Officer $2,758,537 Mixed 30 Jun 2026
Deborah Lee Yount Chief Human Resources Officer $1,765,692 Mixed 01 Mar 2025
B. Kristine Johnson Director $1,596,367 Mixed 18 May 2026
Sven Wehrwein Director $1,533,201 -$1,687,578 -52% Filing P/S 28 Jul 2026
Scott William Drake Director $1,307,602 Mixed 07 May 2021
Regina E. Groves Director $1,137,177 Mixed 18 May 2026
Karen N. Prange Director $884,989 -$224,233 -20% Filing P/S 05 Aug 2026
Deborah H. Telman Director $808,197 Mixed 18 May 2026
Shlomo Nachman Director $703,407 Mixed 18 May 2026
Maggie Yuen Director $538,456 -$241,630 -31% Filing P/S 05 Aug 2026
Tonya Austin Chief Human Resources Officer $534,621 Mixed 13 May 2022

Recent insider transactions for AtriCure, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Karen N. Prange ATRC Common Stock Sale -13.5% $138,283 $38.80 -3,564 22,809 05 Aug 2026 Direct
Maggie Yuen ATRC Common Stock Sale -20% $134,470 $38.42 -3,500 14,015 05 Aug 2026 Direct
Michael H. Carrel ATRC Common Stock Gift -0.6% -4,700 774,434 30 Jul 2026 Direct
Justin J. Noznesky ATRC Common Stock Sale -5.81% $239,862 $38.80 -6,182 100,219 29 Jul 2026 Direct
Vinayak S. Doraiswamy ATRC Common Stock Sale -6.49% $233,280 $38.88 -6,000 86,511 28 Jul 2026 Direct
Sven Wehrwein ATRC Common Stock Sale -38.2% $946,000 $37.84 -25,000 40,518 28 Jul 2026 Direct
Sven Wehrwein ATRC Common Stock Options Exercise 61.7% 25,000 65,518 28 Jul 2026 Direct
Sven Wehrwein ATRC Non-qualified Stock Option (right to buy) Options Exercise -100% -25,000 0 28 Jul 2026 Direct
Michael H. Carrel ATRC Common Stock Award 0.08% 636 779,134 30 Jun 2026 Direct
Vinayak S. Doraiswamy ATRC Common Stock Award 0.69% 636 92,511 30 Jun 2026 Direct
Karl S. Dahlquist ATRC Common Stock Award 0.66% 636 96,689 30 Jun 2026 Direct
Douglas J. Seith ATRC Common Stock Award 0.23% 527 229,867 30 Jun 2026 Direct
Salvatore Privitera ATRC Common Stock Award 0.4% 636 158,684 30 Jun 2026 Direct
Karen N. Prange ATRC Common Stock Sale -10.2% $85,950 $28.65 -3,000 26,373 20 May 2026 Direct
Karen N. Prange ATRC Common Stock Award 26.4% 6,144 29,373 18 May 2026 Direct
Deborah H. Telman ATRC Common Stock Award 27.7% 6,144 28,328 18 May 2026 Direct
Maggie Yuen ATRC Common Stock Award 54% 6,144 17,515 18 May 2026 Direct
Shlomo Nachman ATRC Common Stock Award 33.2% 6,144 24,655 18 May 2026 Direct
B. Kristine Johnson ATRC Common Stock Award 12.3% 6,144 55,954 18 May 2026 Direct
Regina E. Groves ATRC Common Stock Award 18.2% 6,144 39,859 18 May 2026 Direct
Sven Wehrwein ATRC Common Stock Award 17.9% 6,144 40,518 18 May 2026 Direct
Robert S. White ATRC Common Stock Award 5.03% 6,144 128,318 18 May 2026 Direct
Vinayak S. Doraiswamy ATRC Common Stock Sale -5.16% $140,650 $28.13 -5,000 91,875 15 May 2026 Direct
Vinayak S. Doraiswamy ATRC Common Stock Sale -4.91% $149,150 $29.83 -5,000 96,875 12 Mar 2026 Direct
Robert S. White ATRC Common Stock Options Exercise 8.91% 10,000 122,174 10 Mar 2026 Direct
Robert S. White ATRC Non-qualified Stock Option (right to buy) Options Exercise -100% -10,000 0 10 Mar 2026 Direct
Michael H. Carrel ATRC Common Stock Gift -0.76% -6,000 778,498 06 Mar 2026 Direct
Michael H. Carrel ATRC Common Stock Tax liability -8.49% -72,777 784,498 01 Mar 2026 Direct
Michael H. Carrel ATRC Common Stock Award 24.7% 169,898 857,275 01 Mar 2026 Direct
Justin J. Noznesky ATRC Common Stock Tax liability -12.8% -15,586 106,401 01 Mar 2026 Direct
Justin J. Noznesky ATRC Common Stock Award 54.8% 43,189 121,987 01 Mar 2026 Direct
Salvatore Privitera ATRC Common Stock Tax liability -7.67% -13,127 158,048 01 Mar 2026 Direct
Salvatore Privitera ATRC Common Stock Award 36.3% 45,588 171,175 01 Mar 2026 Direct
Vinayak S. Doraiswamy ATRC Common Stock Tax liability -13.3% -15,585 101,875 01 Mar 2026 Direct
Vinayak S. Doraiswamy ATRC Common Stock Award 63.4% 45,588 117,460 01 Mar 2026 Direct
Angela L. Wirick ATRC Common Stock Tax liability -10.1% -22,965 204,893 01 Mar 2026 Direct
Angela L. Wirick ATRC Common Stock Award 38.3% 63,088 227,858 01 Mar 2026 Direct
Douglas J. Seith ATRC Common Stock Tax liability -9.1% -22,948 229,340 01 Mar 2026 Direct
Douglas J. Seith ATRC Common Stock Award 36.8% 67,918 252,288 01 Mar 2026 Direct
Karl S. Dahlquist ATRC Common Stock Tax liability -14% -15,687 96,053 01 Mar 2026 Direct
Karl S. Dahlquist ATRC Common Stock Award 63% 43,189 111,740 01 Mar 2026 Direct
Douglas J. Seith ATRC Common Stock Award 0.14% 257 184,370 31 Dec 2025 Direct
Michael H. Carrel ATRC Common Stock Gift -0.58% -4,000 687,377 10 Dec 2025 Direct
Justin J. Noznesky ATRC Common Stock Sale -6.15% $192,640 $37.29 -5,166 78,798 26 Nov 2025 Direct
Sven Wehrwein ATRC Common Stock Sale -12.6% $188,746 $38.00 -4,967 34,374 25 Nov 2025 Direct
Sven Wehrwein ATRC Common Stock Options Exercise 14.4% 4,967 39,341 25 Nov 2025 Direct
Sven Wehrwein ATRC Non-qualified Stock Option (right to buy) Options Exercise -16.6% -4,967 25,000 25 Nov 2025 Direct
Sven Wehrwein ATRC Common Stock Sale -12.8% $187,832 $37.32 -5,033 34,374 24 Nov 2025 Direct
Sven Wehrwein ATRC Common Stock Options Exercise 14.6% 5,033 39,407 24 Nov 2025 Direct
Sven Wehrwein ATRC Non-qualified Stock Option (right to buy) Options Exercise -14.4% -5,033 29,967 24 Nov 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .